Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02369731
Recruitment Status : Recruiting
First Posted : February 24, 2015
Last Update Posted : February 6, 2020
The John Walton Muscular Dystrophy Research Centre (TREAT-NMD)
Cooperative International Neuromuscular Research Group
Information provided by (Responsible Party):
PTC Therapeutics